London: Good news has come out in the midst of questions being raised about the Corona Vaccine. Two studies in the UK have shown that the risk of infection starts to decrease only after the first dose of the vaccine. Scientists included the Oxford/AstraZeneca or Pfizer/BioNTech vaccine used in Britain in their own research. During this time, he found that the risk of infection reduces by about 65 per cent only after the first dose of the vaccine (First Dose).
The vaccine showed effects on everyone
Although two studies by the University of Oxford and the Office of National Statistics (ONS) have not yet been published, both have found that one in two doses of vaccines has also contributed to the elderly, youth, and healthy people. Has significantly reduced the risk of corona infection. Significantly, there are two doses of the vaccine, the second one is given 28 days after the first dose.
Mask and Social Distancing Emphasis
It is believed that these studies will play an important role in ending the fears raised about the Corona vaccine. People have many types of questions about the vaccine. Even after vaccination, the news of infection has affected their belief about the vaccine, but these studies make it clear how important it is to get the vaccine. However, researchers have cautioned that a person can become infected even after being vaccinated and can spread the deadly virus after being infected without symptoms. For this reason, there is a need to apply the mask and strictly follow social distancing.
Studies are done like this
Researchers analyzed a test report of 350,000 people in the UK between September 2020 and April 2021 and found that coronavirus infection decreased 21 days after the first dose of the vaccine. According to doctors, after vaccination, it takes 21 days for the human body to develop immunity against the coronavirus. The study said that the risk of infection decreased by 65 per cent in those 21 days after the first dose of the vaccine and after the second dose, it decreased by 70 to 77 per cent. In a large-scale study conducted with community surveillance, scientists have concluded that even a single dose of the Oxford-AstraZeneca or Pfizer-BioNotech vaccine significantly reduces the risk of COVID-19.